Clinical trial
Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer…
NCT00148395 · Aktion Bronchialkarzinom e.V., Other · Completed
Key facts
| NCT number | NCT00148395 |
|---|---|
| Title | Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. |
| Official title | Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. |
| Lead sponsor | Aktion Bronchialkarzinom e.V., Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Small-Cell Lung Carcinoma |
| Intervention type | Drug |
| Interventions | Gemcitabine, Navelbine, Carboplatin, Cisplatin, Mitomycin, Ifosfamide |
| Enrollment | 280 |
| Start date | Jun 1, 2002 |
| Completion | Apr 1, 2008 |
| First posted | Sep 8, 2005 |
| Last update posted | Apr 22, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: